Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 1Phase 4 1Phase 1/2 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 9Breast Neoplasms 5Neoplasms 3Neoplasm Metastasis 3Ovarian Neoplasms 2Liver Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Solid Tumor 1Proteinuria 1Peritoneal Neoplasms 1Non-Squamous Non-Small Cell Lung Cancer 1Locally Advanced Colorectal Cancer 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 2toripalimab 1Cisplatin 1Cholangiopancreatography, Endoscopic Retrograde 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Biliary Tract Neoplasms × Bevacizumab × Clear all
NCT07619235 2026-06-01

A Single-arm, Multicenter Clinical Study of Iparomlimab and Toripalimab in Combination With Bevacizumab and Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer

Huazhong University of Science and Technology

Phase 4 Not yet recruiting
32 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡